Importer of Controlled Substances; Notice of Application; Cerilliant Corporation, 69130-69131 [2013-27454]

Download as PDF 69130 Federal Register / Vol. 78, No. 222 / Monday, November 18, 2013 / Notices other public and private entities that apply for COPS Office grants or cooperative agreements will be asked complete the COPS Application Package. The COPS Application Package includes all of the necessary forms and instructions that an applicant needs to review and complete to apply for COPS grant funding. The package is used as a standard template for all COPS programs. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond/reply: It is estimated that 5000 respondents annually will complete the form within 11 hours. (6) An estimate of the total public burden (in hours) associated with the collection: There are an estimated 55,000 total annual burden hours associated with this collection. If additional information is required contact: Jerri Murray, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE., Washington DC 20530. Dated: November 12, 2013. Jerri Murray, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2013–27467 Filed 11–15–13; 8:45 am] BILLING CODE 4410–AT–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application: Johnson Matthey, Inc. Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this is notice that on September 5, 2013, Johnson Matthey, Inc., Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, New Jersey 08066–1742, made application by renewal to the Drug Enforcement Administration (DEA) for registration as an importer of the following basic classes of controlled substances: Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417 (2007). In reference to the non-narcotic raw material, the company plans to import gram amounts to be used as reference standards for sale to its customers. Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substances listed in schedules I or II, which fall under the authority of section 1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B)) may, in the circumstances set forth in 21 U.S.C. 958(i), file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47. Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODW), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than December 18, 2013. This procedure is to be conducted simultaneously with, and independent of, the procedures described in 21 CFR 1301.34(b), (c), (d), (e), and (f). As noted in a previous notice published in the Federal Register on September 23, 1975, 40 FR 43745, all applicants for registration to import a basic class of any controlled substance in schedules I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. § 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied. Dated: November 4, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2013–27448 Filed 11–15–13; 8:45 am] BILLING CODE 4410–09–P mstockstill on DSK4VPTVN1PROD with NOTICES Drug Schedule Coca Leaves (9040) ..................... Thebaine (9333) ........................... Opium, raw (9600) ....................... Noroxymorphone (9668) .............. Poppy Straw Concentrate (9670) II II II II II DEPARTMENT OF JUSTICE Drug Enforcement Administration The company plans to import the listed controlled substances as raw materials, to be used in the manufacture of bulk controlled substances, for distribution to its customers. VerDate Mar<15>2010 17:33 Nov 15, 2013 Jkt 232001 Importer of Controlled Substances; Notice of Application; Cerilliant Corporation Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this is notice that on July 16, 2013, Cerilliant PO 00000 Frm 00091 Fmt 4703 Sfmt 4703 Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665–2402, made application to the Drug Enforcement Administration (DEA) for registration as an importer of the following basic classes of controlled substances: Drug Methaqualone (2565) ................... JWH–250 (6250) .......................... SR–18 also known as RCS–8 (7008). XLR11 (7011) ............................... JWH–019 (7019) .......................... AKB48 (7048) ............................... JWH–081 (7081) .......................... SR–19 also known as RCS–4 (7104). JWH–122 (7122) .......................... UR–144 (7144) ............................. AM–2201 (7201) ........................... JWH–203 (7203) .......................... Parahexyl (7374) .......................... 2C–T–2 (7385) ............................. JWH–398 (7398) .......................... 5-Methoxy-3,4-methylenedioxyamphetamine (7401). N-Hydroxy-3,4-methylenedioxyamphetamine (7402). Bufotenine (7433) ......................... N-Ethyl-1-phenylcyclohexylamine (7455). 1-(1-Phenylcyclohexyl)pyrrolidine (7458). 1-(1-Phenylcyclohexyl)pyrrolidine (7470). 2C–D (7508) ................................. 2C–E (7509) ................................. 2C–H (7517) ................................. 2C–I (7518) .................................. 2C–C (7519) ................................. 2C–N (7521) ................................. 2C–P (7524) ................................. 2C–T–4 (7532) ............................. AM–694 (7694) ............................. Codeine methylbromide (9070) .... Acetylmethadol (9601) ................. Allylprodine (9602) ....................... Alphacetylmethadol except levoalphacetylmethadol (9603). Alphameprodine (9604) ................ Alphamethadol (9605) .................. Benzethidine (9606) ..................... Betacetylmethadol (9607) ............ Betameprodine (9608) .................. Betamethadol (9609) .................... Betaprodine (9611) ....................... Hydroxypethidine (9627) .............. Noracymethadol (9633) ................ Norlevorphanol (9634) .................. Normethadone (9635) .................. Para-Fluorofentanyl (9812) .......... 3-Methylfentanyl (9813) ................ Alpha-methylfentanyl (9814) ........ Acetyl-alpha-methylfentanyl (9815). Beta-hydroxyfentanyl (9830) ........ Beta-hydroxy-3-methylfentanyl (9831). Alpha-methylthiofentanyl (9832) ... 3-Methylthiofentanyl (9833) .......... Thiofentanyl (9835) ...................... Lisdexamfetamine (1205) ............. Glutethimide (2550) ...................... Nabilone (7379) ............................ E:\FR\FM\18NON1.SGM 18NON1 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II II II 69131 Federal Register / Vol. 78, No. 222 / Monday, November 18, 2013 / Notices Schedule Drug mstockstill on DSK4VPTVN1PROD with NOTICES 1-Phenylcyclohexylamine (7460) 1-Piperidinocyclohexane carbonitrile (8603). Alphaprodine (9010) ..................... Hydrocodone (9193) ..................... Levomethorphan (9210) ............... Levorphanol (9220) ...................... Noroxymorphone (9668) .............. Racemethorphan (9732) .............. Remifentanil (9739) ...................... Carfentanil (9743) ......................... Tapentadol (9780) ........................ DEPARTMENT OF JUSTICE II II Drug Enforcement Administration Importer of Controlled Substances, Notice of Registration, Chattem Chemicals, Inc. Dated: November 5, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2013–27481 Filed 11–15–13; 8:45 am] II II II II II II II II II The company plans to import the listed controlled substances for manufacture and distribution to their research and forensic customers conducting drug testing and analysis. Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substance listed in schedules I and II, which fall under the authority of section 1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B)) may, in the circumstances set forth in 21 U.S.C. 958(i), file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47. Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODW), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than December 18, 2013. This procedure is to be conducted simultaneously with, and independent of, the procedures described in 21 CFR 1301.34(b), (c), (d), (e), and (f). As noted in a previous notice published in the Federal Register on September 23, 1975, 40 FR 43745–46, all applicants for registration to import a basic classes of any controlled substances in schedules I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied. Dated: November 5, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2013–27454 Filed 11–15–13; 8:45 am] By Notice dated August 15, 2013, and published in the Federal Register on August 26, 2013, 78 FR 52801, Chattem Chemicals, Inc., 3801 St. Elmo Avenue, Chattanooga, Tennessee 37409, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the following basic classes of controlled substances: Drug Schedule Methamphetamine (1105) ............ 4-Anilino-N-phenethyl-4-piperidine (8333). Phenylacetone (8501) .................. Opium, raw (9600) ....................... Poppy Straw Concentrate (9670) Tapentadol (9780) ........................ 17:33 Nov 15, 2013 Jkt 232001 II II II II The company plans to import the listed controlled substances to manufacture bulk controlled substances for sale to its customers. The company plans to import an intermediate form of Tapentadol (9780); and then to bulk manufacture Tapentadol for distribution to its customers. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417 (2007). DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Chattem Chemicals, Inc., to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. DEA has investigated Chattem Chemicals, Inc., to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. BILLING CODE 4410–09–P VerDate Mar<15>2010 II II PO 00000 Frm 00092 Fmt 4703 Sfmt 4703 BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration; Catalent CTS, LLC By Notice dated August 15, 2013, and published in the Federal Register on August 26, 2013, 78 FR 53800, Catalent CTS, LLC., 10245 Hickman Mills Drive, Kansas City, Missouri 64137, made application to the Drug Enforcement Administration (DEA) to be registered as an importer of the following classes of controlled substances: Drug Marihuana (7360) ......................... Poppy Straw Concentrate (9670) Schedule I II The company plans to import a finished pharmaceutical product containing cannabis extracts in dosage form for a clinical trial study. In addition, the company plans to import an ointment for the treatment of wounds which contains trace amounts of the controlled substances normally found in poppy straw concentrate for packaging and labeling to be used in clinical trials. Comments and requests for any hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417 (2007). DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Catalent CTS, LLC., to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. DEA has investigated Catalent CTS, LLC., that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. E:\FR\FM\18NON1.SGM 18NON1

Agencies

[Federal Register Volume 78, Number 222 (Monday, November 18, 2013)]
[Notices]
[Pages 69130-69131]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-27454]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application; 
Cerilliant Corporation

    Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this 
is notice that on July 16, 2013, Cerilliant Corporation, 811 Paloma 
Drive, Suite A, Round Rock, Texas 78665-2402, made application to the 
Drug Enforcement Administration (DEA) for registration as an importer 
of the following basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Methaqualone (2565)........................  I
JWH-250 (6250).............................  I
SR-18 also known as RCS-8 (7008)...........  I
XLR11 (7011)...............................  I
JWH-019 (7019).............................  I
AKB48 (7048)...............................  I
JWH-081 (7081).............................  I
SR-19 also known as RCS-4 (7104)...........  I
JWH-122 (7122).............................  I
UR-144 (7144)..............................  I
AM-2201 (7201).............................  I
JWH-203 (7203).............................  I
Parahexyl (7374)...........................  I
2C-T-2 (7385)..............................  I
JWH-398 (7398).............................  I
5-Methoxy-3,4-methylenedioxy-amphetamine     I
 (7401).
N-Hydroxy-3,4-methylenedioxy-amphetamine     I
 (7402).
Bufotenine (7433)..........................  I
N-Ethyl-1-phenylcyclohexylamine (7455).....  I
1-(1-Phenylcyclohexyl)pyrrolidine (7458)...  I
1-(1-Phenylcyclohexyl)pyrrolidine (7470)...  I
2C-D (7508)................................  I
2C-E (7509)................................  I
2C-H (7517)................................  I
2C-I (7518)................................  I
2C-C (7519)................................  I
2C-N (7521)................................  I
2C-P (7524)................................  I
2C-T-4 (7532)..............................  I
AM-694 (7694)..............................  I
Codeine methylbromide (9070)...............  I
Acetylmethadol (9601)......................  I
Allylprodine (9602)........................  I
Alphacetylmethadol except levo-              I
 alphacetylmethadol (9603).
Alphameprodine (9604)......................  I
Alphamethadol (9605).......................  I
Benzethidine (9606)........................  I
Betacetylmethadol (9607)...................  I
Betameprodine (9608).......................  I
Betamethadol (9609)........................  I
Betaprodine (9611).........................  I
Hydroxypethidine (9627)....................  I
Noracymethadol (9633)......................  I
Norlevorphanol (9634)......................  I
Normethadone (9635)........................  I
Para-Fluorofentanyl (9812).................  I
3-Methylfentanyl (9813)....................  I
Alpha-methylfentanyl (9814)................  I
Acetyl-alpha-methylfentanyl (9815).........  I
Beta-hydroxyfentanyl (9830)................  I
Beta-hydroxy-3-methylfentanyl (9831).......  I
Alpha-methylthiofentanyl (9832)............  I
3-Methylthiofentanyl (9833)................  I
Thiofentanyl (9835)........................  I
Lisdexamfetamine (1205)....................  II
Glutethimide (2550)........................  II
Nabilone (7379)............................  II

[[Page 69131]]

 
1-Phenylcyclohexylamine (7460).............  II
1-Piperidinocyclohexane carbonitrile (8603)  II
Alphaprodine (9010)........................  II
Hydrocodone (9193).........................  II
Levomethorphan (9210)......................  II
Levorphanol (9220).........................  II
Noroxymorphone (9668)......................  II
Racemethorphan (9732)......................  II
Remifentanil (9739)........................  II
Carfentanil (9743).........................  II
Tapentadol (9780)..........................  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
manufacture and distribution to their research and forensic customers 
conducting drug testing and analysis.
    Any bulk manufacturer who is presently, or is applying to be, 
registered with DEA to manufacture such basic classes of controlled 
substance listed in schedules I and II, which fall under the authority 
of section 1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B)) may, in 
the circumstances set forth in 21 U.S.C. 958(i), file comments or 
objections to the issuance of the proposed registration and may, at the 
same time, file a written request for a hearing on such application 
pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 
1316.47.
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODW), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than December 18, 2013.
    This procedure is to be conducted simultaneously with, and 
independent of, the procedures described in 21 CFR 1301.34(b), (c), 
(d), (e), and (f). As noted in a previous notice published in the 
Federal Register on September 23, 1975, 40 FR 43745-46, all applicants 
for registration to import a basic classes of any controlled substances 
in schedules I or II are, and will continue to be, required to 
demonstrate to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, that the requirements for 
such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 
21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied.

    Dated: November 5, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-27454 Filed 11-15-13; 8:45 am]
BILLING CODE 4410-09-P